Sanofi India gets GST show cause notice over product classification

Regulatory & Legal View source PDF Explain this filing

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹3116.00

prior close

₹3115.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%+2.1% vs market

Pharmaceuticals peers, median of 175sector-0.3%+1.5% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+0.8

15m

+0.9

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2-1.0+2.1-0.3+1.5

Next day

+1.4-1.5+3.0-0.5+2.0

+2.8-0.9+3.8+0.0+2.8

+1.2-0.3+1.5+0.2+1.0

+0.1+0.1-0.0+0.2-0.1

+0.1+0.7-0.5+0.9-0.7

-0.2+0.3-0.5+0.3-0.5

15d

-1.9+1.0-2.8+0.8-2.6

-2.4-2.4-0.1-1.2-1.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sanofi India received a show cause notice from GST authorities on 31 Aug 2026, alleging the company misclassified some products at 5 percent GST instead of 12 percent for FY 2020-21. The proposed tax liability is Rs 36.39 crore with an equal proposed penalty of Rs 36.39 crore. The company is reviewing the notice with tax advisors and plans to respond within the prescribed period. Sanofi says it does not foresee any material adverse impact on its financials or operations from this notice.

Likely market impact

Show cause stage only, no penalty imposed yet. Company will contest; total potential exposure about Rs 73 crore if decided against it.